AI prediction technology for better targeted patient selection in clinical trials
– Automated prediction of clinical progression based on patient’s MRI and clinical data
– Robust algorithms pre-trained on large US/EU databases – optimizable using data from a specific clinical trial
– Adjustable selection sensitivity for an optimal trade-off between screening cost & success likelihood
– Automated reporting with easily interpretable results